Quantifying the fitness benefit and cost of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy (2017)

First Author: Whittles L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/121418

Publication URI: http://dx.doi.org/10.1101/121418

Type: Preprint